Axonics Retained Earnings (Accumulated Deficit) 2017-2024 | AXNX
Axonics Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
---|---|
2023 | $-380 |
2022 | $-374 |
2021 | $-315 |
2020 | $-234 |
2019 | $-180 |
2018 | $-100 |
2017 | $-67 |
2016 | $-49 |
Axonics Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
---|---|
2024-06-30 | $-393 |
2024-03-31 | $-399 |
2023-12-31 | $-380 |
2023-09-30 | $-387 |
2023-06-30 | $-391 |
2023-03-31 | $-384 |
2022-12-31 | $-374 |
2022-09-30 | $-375 |
2022-06-30 | $-359 |
2022-03-31 | $-337 |
2021-12-31 | $-315 |
2021-09-30 | $-299 |
2021-06-30 | $-282 |
2021-03-31 | $-257 |
2020-12-31 | $-234 |
2020-09-30 | $-223 |
2020-06-30 | $-214 |
2020-03-31 | $-194 |
2019-12-31 | $-180 |
2019-09-30 | $-157 |
2019-06-30 | $-132 |
2019-03-31 | $-113 |
2018-12-31 | $-100 |
2018-09-30 | $-90 |
2018-06-30 | |
2018-03-31 | |
2017-12-31 | |
2017-09-30 | |
2016-12-31 | $-49 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $3.602B | $0.366B |
Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $11.978B | 0.00 |
Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
Privia Health (PRVA) | United States | $2.736B | 228.00 |
Enovis (ENOV) | United States | $2.646B | 17.94 |
Omnicell (OMCL) | United States | $2.263B | 74.03 |
Azenta (AZTA) | United States | $2.242B | 127.33 |
10x Genomics (TXG) | United States | $1.925B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
Schrodinger (SDGR) | United States | $1.422B | 0.00 |
Phreesia (PHR) | United States | $1.252B | 0.00 |
Standard BioTools (LAB) | United States | $0.830B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.586B | 0.00 |
Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
Pulmonx (LUNG) | United States | $0.298B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
TruBridge (TBRG) | United States | $0.214B | 62.22 |
P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
American Well (AMWL) | United States | $0.139B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.064B | 0.00 |
111 (YI) | China | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.050B | 0.00 |
Outset Medical (OM) | United States | $0.045B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
CareCloud (CCLD) | United States | $0.042B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |